Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
47
DFP Quote, Financials, Valuation and Earnings
Last price:
$20.25
Seasonality move
:
-1.96%
Day range:
$20.10 - $20.28
52-week range:
$17.75 - $21.73
Dividend yield:
7.07%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
41K
Avg. volume:
55K
1-year change:
10.92%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Analysts' Opinion
-
Consensus RatingFlaherty & Crumrine Pref&Inc Allocation has received a consensus rating of Buy. The company's average rating is a Buy based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Flaherty & Crumrine Pref&Inc Allocation has an estimated downside of -- from its current price of $20.22.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $20.22.
Fair Value
-
According to the consensus of 0 analysts, Flaherty & Crumrine Pref&Inc Allocation has -- downside to fair value with a price target of -- per share.
DFP vs. S&P 500
-
Over the past 5 trading days, Flaherty & Crumrine Pref&Inc Allocation has overperformed the S&P 500 by 0.63% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Flaherty & Crumrine Pref&Inc Allocation does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Flaherty & Crumrine Pref&Inc Allocation has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Flaherty & Crumrine Pref&Inc Allocation reported revenues of --.
Earnings Growth
-
Flaherty & Crumrine Pref&Inc Allocation has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Flaherty & Crumrine Pref&Inc Allocation reported earnings per share of --.
Enterprise value:
--
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
--
Return On Assets:
--
Net Income Margin (TTM):
--
Return On Equity:
--
Return On Invested Capital:
--
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2018-11-30 | 2019-11-30 | 2020-11-30 | 2021-11-30 | 2022-11-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $7.4M | $6.9M | $7M | $15.8M | $7.8M | |
| Total Assets | $696.2M | $755.4M | $761.6M | $816.8M | $706.4M | |
| Current Liabilities | $2.8M | $1.1M | $730K | $853K | $1.6M | |
| Total Liabilities | $255M | $253.3M | $253M | $277.2M | $277.9M | |
| Total Equity | $441.2M | $502.1M | $508.7M | $539.7M | $428.4M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-12-23 | 2023-12-23 | 2023-12-23 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
DFP
Sector
Market Cap
--
--
Price % of 52-Week High
93.05%
--
Dividend Yield
7.07%
--
Shareholder Yield
--
--
1-Year Price Total Return
10.92%
--
Beta (5-Year)
0.916
--
Dividend yield:
7.07%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$20.35
200-day SMA
Buy
Level
$19.71
Bollinger Bands (100)
Sell
Level
19.98 - 21.14
Chaikin Money Flow
Sell
Level
-5.4M
20-day SMA
Sell
Level
$20.45
Relative Strength Index (RSI14)
Sell
Level
41.20
ADX Line
Buy
Level
7.89
Williams %R
Neutral
Level
-69.863
50-day SMA
Sell
Level
$20.53
MACD (12, 26)
Sell
Level
-0.08
25-day Aroon Oscillator
Sell
Level
-36
On Balance Volume
Neutral
Level
317.6K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
--
CA Score
(Annual)
Level (--)
--
Beneish M-Score
(Annual)
Level (--)
Buy
Momentum Score
Level (8)
--
Ohlson Score
Level (--)
--
Piotroski F Score
(Annual)
Level (--)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Flaherty & Crumrine Pref&Inc Allocation is a diversified, closed-end management investment company. Its investment objective is to seek total return, with an emphasis on high current income.
Stock Forecast FAQ
In the current month, DFP has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The DFP average analyst price target in the past 3 months is --.
-
Where Will Flaherty & Crumrine Pref&Inc Allocation Stock Be In 1 Year?
According to analysts, the consensus estimate is that Flaherty & Crumrine Pref&Inc Allocation share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Flaherty & Crumrine Pref&Inc Allocation?
Analysts are divided on their view about Flaherty & Crumrine Pref&Inc Allocation share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Flaherty & Crumrine Pref&Inc Allocation is a Sell and believe this share price will rise from its current level to --.
-
What Is Flaherty & Crumrine Pref&Inc Allocation's Price Target?
The price target for Flaherty & Crumrine Pref&Inc Allocation over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is DFP A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Flaherty & Crumrine Pref&Inc Allocation is a Buy. 0 of 0 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of DFP?
You can purchase shares of Flaherty & Crumrine Pref&Inc Allocation via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Flaherty & Crumrine Pref&Inc Allocation shares.
-
What Is The Flaherty & Crumrine Pref&Inc Allocation Share Price Today?
Flaherty & Crumrine Pref&Inc Allocation was last trading at $20.25 per share. This represents the most recent stock quote for Flaherty & Crumrine Pref&Inc Allocation. Yesterday, Flaherty & Crumrine Pref&Inc Allocation closed at $20.22 per share.
-
How To Buy Flaherty & Crumrine Pref&Inc Allocation Stock Online?
In order to purchase Flaherty & Crumrine Pref&Inc Allocation stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 23
Quantum [QMCO] is up 14.24% over the past day.
Sell
46
NUKK alert for Dec 23
Nukkleus [NUKK] is up 22.5% over the past day.
Sell
1
IIPR alert for Dec 23
Innovative Industrial Properties [IIPR] is down 2.2% over the past day.
